New York, New York (PRWEB) March 19, 2014 -- Testosterone treatment lawsuits (http://www.testosteronelawsuitcenter.com/ ) continue to be filed in courts around the country on behalf of men who allegedly suffered serious heart problems due to their use of AndroGel, Testim and other low testosterone therapies, Bernstein Liebhard LLP reports. Court documents indicate that an Alabama man has filed what might be the first testosterone lawsuit in the state of Pennsylvania against the manufacturer of Testim. According to the complaint, which is pending in the Philadelphia Court of Common Pleas on March 17, 2014, the 64-year-old Plaintiff began using Testim in 2011, and at the time had no prior history of cerebrovascular disease or neurological impairments. (Case No. 140301684)
Among other things, the lawsuit alleges that the Plaintiff’s use of Testim resulted in a “cardiovascular accident,” and an eventual diagnosis of concomitant erythrocytosis and clinical hyperviscosity syndrome. Three to four months after he discontinued treatment with Testim, the Plaintiff’s hematocrit levels returned to normal, according to the complaint.
“This complaint joins several other testosterone treatment lawsuits that have been filed in courts around the country since federal health regulators raised concerns about the heart risks associated with AndroGel, Testim, and similar medications earlier this year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal reviews to anyone who may have suffered serious heart attacks, strokes, deep vein thrombosis or pulmonary embolism, allegedly due to the use of prescription testosterone therapies.
Testosterone Treatment Lawsuits
According to court documents, testosterone therapies like AndroGel and Testim are approved to treat hypogonadism (low or no testosterone) in men who suffer from the condition due to an underlying illness or injury. In January 2014, the U.S. Food & Drug Administration (FDA) revealed that it had launched a safety review of prescription testosterone therapies after two studies found a high rate of serious cardiovascular events in men with preexisting heart problems who used the medications. The FDA has not yet concluded that these drugs will raise the risk of such heart events, but has advised doctors to weigh their risk and benefits when they are prescribed.
Since then, court records indicate that a number of testosterone treatment lawsuits have been filed in courts around the country on behalf of men who suffered serious heart injuries, allegedly due to their use of these medications. In addition to the case pending in Pennsylvania, a Testim lawsuit was filed on February 26, 2014, in the U.S. District Court, Northern District of California by a man who claims his use of the testosterone therapy resulted in a stroke. (Case No. No. 14-278)
Court documents filed in the U.S. District Court, Northern District of Indiana indicate that five AndroGel lawsuits are currently pending in that jurisdiction. These include four cases filed on February 4th on behalf of men who allegedly suffer heart attacks, strokes and heart failure due to their use of the medication. (Case Nos: 1:14-cv-00776, 1:14-cv-00780, 1:14-cv-00777, and 1:14-cv-00772) The Fifth AndroGel lawsuit was filed on February 10th and claimed that the Plaintiff suffered pulmonary embolism, deep vein thrombosis, and other serious cardiovascular injuries after using multiple doses of the drug. (Case: 1:14-cv-00917)
Men who suffered severe cardiovascular injuries, allegedly due to their use of AndroGel, Testim and other prescription testosterone therapies may be entitled to compensation from the manufacturers of these drugs. To learn more about filing a testosterone lawsuit, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
Felecia L. Stern, Testosterone Lawsuit Information Center, http://www.testosteronelawsuitcenter.com/, +1 800-511-5092, [email protected]
SOURCE Testosterone Lawsuit Information Center